Abstract
Purpose. The gastric mucoadhesive property of tetracycline-sucralfate acidic complex (CO) was evaluated by using a novel method in vitro to compare with the in vivo test. The mucoadhesive mechanism of the acidic complex was also studied.
Methods. The gastric mucosa removed from a rat was placed covering the end of a plunger and secured in a disposable syringe. The acidic test medium was gradually infused in and then flowed out. Two different kinds of CO, tetracycline, or a physical mixture (PM) were introduced into the device to compare their mucoadhesive properties. The tetracycline content in the residue on the mucosa was measured. The results were compared with those of the in vivo test. The acidic response of CO and the protein binding capacity of a sucrose octa-sulfate group (SOS) in sucralfate or CO were evaluated.
Results. The mucoadhesive properties of CO were clearly superior to those of PM. The remaining amounts of tetracycline in each test sample, determined by the in vitro test, were in agreement with those of the in vivo test. The excellent mucoadhesive property of CO appeared to be caused by the rapid response to the acid and resulting mucoadhesive gel formation. Furthermore, the binding capacity of SOS to the protein was clearly greater than that of PM. The excessive acid treatment during the preparation of CO tended to decrease the mucoadhesive property.
Conclusions. CO appeared to be potentially useful for the eradication of Helicobacter pylori because of the direct delivery of tetracycline to the gastric mucosa for an extended period of time.
Similar content being viewed by others
References
T. Lind, S. V. van Zanten, P. Unge, R. Spiller, E. Bayerdorffer, C. Morain, K. D. Bardhan, M. Bradette, N. Chiba, M. Wrangstadh, C. Cederberg, and J. P. Idstrom. Eradication of Helicobacter pylori using one-week triple therapy combining Omeprazole with two antimicrobials: The mach I study. Helicobacter 1:138-144 (1996).
A. A. van Zwet, C. M. J. E. Vandenbroucke-Grauls, J. C. Thijs, E. J. van der Wouden, M. M. Gerrits, and J. G. Kusters. Stable amoxicilline resistance in Helicobacter pylori. Lancet 352:1595(1998).
N. Vakil, B. Hahn, and D. McSorley. Clarithromycin-resistant Helicobacter pylori in patients with duodenal ulcer in the United States. Am. J. Gastroenterol. 93:1432-1435 (1998).
L. L. Thomsen, J. B. Gavin, and C. Tasman-Jones. Relation of Helicobacter pylori to the human gastric mucosa in chronic gastritis of the antrum. Gut 31:1230-1236 (1990).
H. Blanco-Fuente, S. Anguiano-Igea, F. J. Otero-Espinar, and J. Blanco-Mendez. In-vitro bioadhesion of carbopol hydrogels. Int J. Pharm. 142:169-174 (1996).
S. Tamburic and D. Q. M. Craig. An investigation into the rheological, dielectric and mucoadhesive properties of poly (acrylic acid) gel systems. J. Control. Rel. 37:59-68 (1995).
K. Pritchard, A. B. Lansley, G. P. Martin, M. Helliwell, C. Marriott, and L. M. Benedetti. Evaluation of the bioadhesive properties of hyaluronan derivatives: detachment weight and mucociliary transport rate studies. Int. J. Pharm. 129:137-145 (1996).
C. Prudat-Christiaens, P. Arnaud, P. Allain, and J. C. Chaumeil. Aminophylline bioadhesive tablets attempted by wet granulation. Int. J. Pharm. 141:109-116 (1996).
M. F. Saettone, P. Chetoni, M. T. Torracca, S. Burgalassi, and B. Giannaccini. Evaluation of muco-adhesive properties and in vivo activity of ophthalmic vehicles based on hyaluronic acid. Int. J. Pharm. 51:203-212 (1989).
H. S. Chng, H. Park, P. Kelly, and J. R. Robinson. Bioadhesive polymers as platforms for oral controlled drug delivery II: synthesis and evaluation of some swelling, water-insoluble bioadhesive polymers. J. Pharm. Sci. 74:399-405 (1985).
H. Katayama, T. Nishimura, S. Ochi, Y. Tsuruta, Y. Yamazaki, K. Shibata, and H. Yoshitomi. Sustained release liquid preparation using sodium alginate for eradication of Helicobacter pylori. Biol. Pharm. Bull. 22:55-60 (1999).
C. Tasman-Jones, G. Morrison, L. Thomsen, and M. Vanderwee. Sucralfate interactions with gastric mucus. Am. J. Med. 86:5-9 (1989).
F. Nakamura, R. Ohta, Y. Machida, and T. Nagai. In vitro and in vivo nasal mucoadhesion of some water-soluble polymers. Int. J. Pharm. 134:173-181 (1996).
R. Hejazi and M. Amiji. Stomach-specific anti-H. pylori therapy. I: preparation and characterization of tetracycline-loaded chitosan microspheres. Int. J. Pharm. 235:87-94 (2002).
C. H. Lee and Y. W. Chien. Development and evaluation of a mucoadhesive drug delivery system for dual-controlled delivery of Nonoxynol-9. J. Control. Rel. 39:93-103 (1996).
R. Nagashima, Y. Hinohara, T. Hirano, and H. Kamiyama. Selective binding of sucralfate to ulcer lesion: II. Experiments in rats with gastric ulcer receiving 14C-sucralfate or potassium 14C-sucrose sulfate. Arzneim-Forsh./Drug Res. 30:84-88 (1980).
R. Nagashima. Mechanism of action of sucralfate. J. Clin. Gastroenterol. 3:117-127 (1981).
S. Nakazawa, R. Nagashima, and M. Samloff. Selective binding of sucralfate to gastric ulcer in man. Dig. Dis. Sci. 26:297-300 (1981).
M. Romano, M. Razandi, and K. J. Ivey. Effect of sucralfate and its components on taurocholate-induced damage to rat gastric mucosal cell in tissue culture. Dig. Dis. Sci. 35:467-476 (1990).
G. P. Morris, C. M. Keenan, W. K. Macnaughton, J. L. Wallace, and T. E. Williamson. Protection of rat gastric mucosa by sucralfate. Am. J. Med. 86:10-16 (1989).
R. A. Yokel, K. M. Dickey, and A. H. Goldberg. Selective adherence of a sucralfate-tetracycline complex to gastric ulcers: implications for the treatment of Helicobacter pylori. Biopharm. Drug Dispos. 16:475-479 (1995).
H. Oka, H. Matsumoto, K. Uno, K. Harada, S. Kadowaki, and M. Suzuki. Improvement of chemical analysis of antibiotics. VIII. J. Chromatogr. 325:265-274 (1985).
H. Oka, K. Uno, K. Harada, and M. Suzuki. Improvement of chemical analysis of antibiotics. II. Yakugaku-Zasshi. 103:531-537 (1983).
H. Terada, M. Asanoma, and Y. Sakabe. Studies on residual antibacterials in foods. I. Eisei-Kagaku 30:138-143 (1984).
Y. Hoshino, M. Horie, N. Nose, and H. Iwasaki. Determination of tetracyclines and macrolide residues in meats by high performance liquid chromatography. Shokuhin-Eiseigaku-Zasshi 25:430-435 (984).
M. J. Tobyn, J. R. Johnson, and P. W. Dettman. Factors affecting in vitro gastric mucoadhesion I: test condition and instrumental parameters. Eur. J. Pharm. Biopharm. 41:235-241 (1995).
M. R. Jimenez-Castellanos, H. Zia, and C. T. Rhodes. Assessment of an in vitro method for measuring the bioadhesiveness of tablets. Int. J. Pharm. 89:223(1993).
C. Charrueau, P. Aruaud, J. Durieux, P. Allain, and J. C. Chaumeil. Oropharyngeal decontamination, bioadhesive power mixture formation: choice of the bioadhesive material. J. Control. Rel. 26:49-57 (1993).
M. Rillosi and G. Buckton. Modelling mucoadhesion by use of surface energy terms obtained by the lewis and-lewis base approach. Int. J. Pharm. 117:75-84 (1995).
A. A. Attama, M. U. Adikwu, and N. D. Okoli. Studies on bioadhesive granules I: granules formation with Prosopis africana (prosopis) gum. Chem. Pharm. Bull. 48:734-737 (2000).
J. D. Smart, I. W. Kellaway, and H. E. C. Worthington. An in-vitro investigation of mucosa-adhesive materials for use in controlled drug delivery. J. Pharm. Pharmacol. 36:295-299 (1984).
R. Nagashima and N. Yoshida. Sucralfate, a basic aluminum salt of sucrose sulfate: I. Behaviors in gastroduodenal pH. Arzneim.-Forsh./Drug Res. 29:1668-1676 (1979).
R. Nagashima, N. Yoshida, and N. Terao. Sucralfate, a basic aluminum salt of sucrose sulfate: II. Inhibition of peptic hydrolysisas it from sucrose sulfate interaction with protein substrate, serum albumins. Arzneim.-Forsh./Drug Res. 30:73-76 (1980).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Higo, S., Ori, K., Takeuchi, H. et al. A Novel Evaluation Method of Gastric Mucoadhesive Property in Vitro and the Mucoadhesive Mechanism of Tetracycline-Sucralfate Acidic Complex for Eradication of Helicobacter pylori . Pharm Res 21, 413–419 (2004). https://doi.org/10.1023/B:PHAM.0000019293.57927.7f
Issue Date:
DOI: https://doi.org/10.1023/B:PHAM.0000019293.57927.7f